✦ LIBER ✦

Computational Study of KNI-272, a Potent Inhibitor of HIV-1 Protease: On the Mechanism of Preorganization

✍ Scribed by David, Laurent; Luo, Ray; Head, Martha S.; Gilson, Michael K.

Book ID: 126306482
Publisher: American Chemical Society
Year: 1999
Tongue: English
Weight: 281 KB
Volume: 103
Category: Article
ISSN: 0022-3654
DOI: 10.1021/jp983675l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thermodynamic dissection of the binding

Thermodynamic dissection of the binding energetics of KNI-272, a potent HIV-1 protease inhibitor

✍ Adrian Velazquez-Campoy; Irene Luque; Matthew J. Todd; Mark Milutinovich; Yoshia 📂 Article 📅 2000 🏛 Cold Spring Harbor Laboratory Press 🌐 English ⚖ 344 KB

Targets of a protease inhibitor, KNI-272

Targets of a protease inhibitor, KNI-272, in HIV-1-infected cells

✍ Toshiyuki Goto; Takashi Nakano; Takehiro Kohno; Shinichi Morimatsu; Chizuko Mori 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Physiologically based pharmacokinetics o

Physiologically based pharmacokinetics of KNI-272, a tripeptide HIV-1 protease inhibitor

✍ Akiko Kiriyama; Tomoyuki Nishiura; Hirokazu Yamaji; Kanji Takada 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

The effects of dose on the pharmacokinetic characteristics of KNI-272 were evaluated in rats after intravenous (iv) administration. The plasma kinetics of KNI-272 were dose-independent within a dose range of 1.0 to 10.0 mg/kg. However, when the dose was increased to 50.0 mg/kg, the area under the pl

Conformational analysis of HIV-1 proteas

Conformational analysis of HIV-1 protease inhibitors: 2. Thioproline P1? Residue in the potent inhibitor KNI-272

✍ Murcko, Mark A.; Rao, B. Govinda; Gomperts, Roberto 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

does not contain a basic amine as do Saquinovir and JG-365, for example it should be easier to desolvate, which also assists in binding. The relationship between KNI-272, JG-365, Saquinovir, and P X proline-containing substrate also is 1

BINDING CHARACTERISTICS OF KNI-272 TO PL

BINDING CHARACTERISTICS OF KNI-272 TO PLASMA PROTEINS, A NEW POTENT TRIPEPTIDE HIV PROTEASE INHIBITOR

✍ A. Kiriyama; T. Nishiura; M. Ishino; Y. Yamamoto; I. Ogita; Y. Kiso; K. Takada 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 690 KB

The binding characteristics of KNI-272, a potent and selective human immunodeficiency virus (HIV) protease inhibitor, were evaluated in rat and human plasma, and in solutions of human a,-acid glycoprotein (AAG) and human serum albumin (HSA). The unbound fractions (F,) of KNI-272 were 12.13 and 2.24%

Flexibility and Function in HIV Protease

Flexibility and Function in HIV Protease: Dynamics of the HIV-1 Protease Bound to the Asymmetric Inhibitor Kynostatin 272 (KNI-272)

✍ Freedberg, Darón I.; Wang, Yun-Xing; Stahl, Stephen J.; Kaufman, Joshua D.; Wing 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 123 KB